04/25/2024
6:15 AM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
5:46 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
3:07 PM | Sage Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024
3:10 PM | Sage Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024
3:13 PM | Sage Therapeutics (Filer)
| Form ARS | |
04/19/2024
7:31 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
5:35 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/26/2024
7:34 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
6:49 AM | Sage Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2024
6:20 AM | Sage Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
6:09 AM | RTW INVESTMENTS, LP (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
4:13 PM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/13/2024
5:28 AM | Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024
5:28 AM | BB BIOTECH AG (Filed by)
BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024
9:17 AM | Sage Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/31/2024
4:25 PM | Sage Therapeutics (Subject)
| Form SC TO-I/A | |
01/31/2024
3:50 PM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2024
9:04 AM | Sage Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
01/23/2024
7:13 AM | Sage Therapeutics (Subject)
| Form SC TO-I | |
01/08/2024
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:07 PM | IGUCHI KIMI (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | Golumbeski George (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | FRATES JAMES M (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | PAUL STEVEN M (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | Federer Jessica (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
7:30 AM | Sage Therapeutics (Filer)
| Form DEF 14A | |
12/19/2023
7:32 AM | Sage Therapeutics (Filer)
| Form DEFA14A | |
12/08/2023
8:00 AM | Sage Therapeutics (Subject)
| Form SC TO-C | |
12/08/2023
7:30 AM | Sage Therapeutics (Filer)
| Form PRE 14A | |
12/08/2023
7:30 AM | Sage Therapeutics (Filer)
| Form PRE 14A | |
11/07/2023
6:39 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
6:29 AM | Sage Therapeutics (Filer)
| Form 424B5 | |
11/07/2023
6:00 AM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
5:46 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/31/2023
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
7:51 AM | Barrett Elizabeth (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
6:49 AM | Sage Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/07/2023
6:20 AM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2023
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
07/10/2023
7:44 AM | Sage Therapeutics (Subject)
| Form SC 13G/A | |
07/10/2023
7:44 AM | Sage Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
05/11/2023
7:58 AM | Barrett Elizabeth (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:21 AM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2023
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
